期刊文献+

卡维地洛制备工艺改进研究 被引量:1

Improvent of synthesis process for carvedilol
下载PDF
导出
摘要 目的:研究卡维地洛的合成并进行工艺改进。方法:以4-羟基咔唑为起始原料,经过缩合、氢解脱除苄基得到目标产物,反应过程采用薄层层析进行监控。结果:该反应总收率为48.3%。目标产物经红外光谱、核磁共振及元素分析确证了其化学结构。结论:改进后的工艺,反应条件温和,质量和收率有较大的提高,环境污染小,适合工业化生产。 Objective: To study and improve the synthesis of carvedilol.Methods: Carvediol was high effectively synthesized from 4-hydroxy carbazole by condensation with epichlorohydrin,N-[2-(2-methoxy-phenoxy)ethyl]benzylamine;debenzylated by catalytic hydrogenation.Results: The overall yield was 48.3%.The chemical structures of target product were characterized by IR,NMR and element analysis.Conclusion: This synthetic route is simple and suitable for industrialized production with lower cost,lower pollution and higher yield.
出处 《中国医药导报》 CAS 2011年第18期76-77,共2页 China Medical Herald
关键词 4-羟基咔唑 卡维地洛 缩合反应 脱苄基反应 4-hydroxy carbazole Carvedilol Condensation Debenzylated
  • 相关文献

参考文献7

二级参考文献20

  • 1施仲伟.β受体阻滞剂治疗慢性心力衰竭的目标剂量问题[J].中华老年多器官疾病杂志,2004,3(3):226-229. 被引量:7
  • 2Packer M, Coasts A J, Fowler M B, et al. Effect of carvedilol on survival in severe chronic heart failure[J]. N Engl J Med,2001, 344(22) :1651 - 1658.
  • 3Bristow M R. What type of beta - blocker should be used to treat chronic heart failure [J].Circulation, 2001,10:484 - 486.
  • 4Merit - HF Study Group. Effect of metoprolol CR/XL in chronic heart failure : metoprolol CR/XL randomized intervention trial in congestive heart failure ( MERIT - HF) [ J ]. Lancet, 1999,353 : 2001 - 2007.
  • 5Bristow M R. Mechanism of action of beta - blocking agents in heart failure[ J ]. Am J Cardiol, 1997,80:26L - 40L.
  • 6Stoschitzky K, Koshueharova G, Zweiker R, et al. Differing beta - blocking effects of carvedilol and metoprolol [ J ]. Eur J Heart Fail ,2001,3 ( 3 ) :343 - 349.
  • 7Barr C S, Naas A, Freeman M, et al. QT dispersion and sudden unexpected death in chronic heart failure[ J]. Lancet, 1994,343 (8893) :327 - 329.
  • 8Bril A, Tomasi V, Lville M P. Antiarrhythmic effect of carvedilol in rat isolated heart subjected to regional ischaemia and reperfusion[ J]. Pbarmaeol Commun, 1995,5:291 - 300.
  • 9ZENG Ling-hui(曾玲晖). The relation of cardiology disease and function of vascular endothelium [J]. Journal of Zhejiang Medical University(浙江医科大学学报),1998,27(4):190-192.(in Chinese)
  • 10Bobik A, Grooms A, Millar J A, et al. Growth factor activity of endothelin on vascular Smooth muscle [J]. Am J Physiol, 1990,258(3Pt1):C408-C415.

共引文献5

同被引文献18

  • 1Lysko P G,Lysko K A,Yue TL,et al.Neuroprotective effects of carvedilol.a new antihypertensive agent,in cultured rat cerebellar neurons and in gerbil global brain ischemia[J].Stroke Journal of the American Heart Association,1992,23(11):1630-1635.
  • 2McTavish D,Compoli-Richards D,Sorkin E M.Carvedilol,A review of its pharmacodynamic and pharmacokinetic properties,and therapeutic efficacy[J].Drugs,1993,45(2):232-258.
  • 3Ramanjaneyulu G S, Kumar I V S,Rao KN,et al.Process for the preparation of crystalline carvedilol form-II:WO,2004094378[P].2004-11-04.
  • 4Wiedemann F,Kampe W,Thiel M,et al.Carbazolyl-(4)-oxy-propanolamin-derivate , verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel:EP,0004920A1[P].1979-10-31.
  • 5Sergey F,Aronhime J,Dolitzky B Z,et al.Carvedilol:WO,0200216A1[P].2001-06-28.
  • 6周世伟,蹇锋.一种卡维地洛的制备方法:中国,102190613A[P],2011-09-21.
  • 7Jozsef B,SimigG,TamasG,et al.Process and intermediates for preparing 1-[9'H-carbazol-4'-yloxy]-3-[2"-(2'"-methoxy-phenoxy)- ethyl-amino]-propan-2-ol[carvedil-ol]:EP,0918055-A1[P].1998-11-24.
  • 8Fischer E,PitteIkow T,TreppendahI S V,et al.Process and intermediates for the preparationof 1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxy-phenoxy)-ethylamino]-propan-2-ol,carvedilol or acid addition salts thereof:WO,2001087837A1[P].2001-11-22.
  • 9Amdt K S,Kolter D,Danielmeier K, et al.Electrogenerated chiral 4-methoxy-2-oxazolidinonesas diastereoselective amidoalkylation reagents for the synthesis of beta-amino alcohol precursors[J].Eur.J,Org.Chem.,2001,2001(13):2425.
  • 10Madhusudhan G , Anand Kumar B,Chintamani U S,etal.Aficile synthesis of Carvedilol β-adrenergic blocking agent,via a key 5-substituted-2-oxazolidinoneintermediate[J].IJC: B,2010,49B C5):606-610.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部